Literature DB >> 11588855

Insulin-like growth factors and prostate cancer.

M Pollak1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11588855     DOI： 10.1093/oxfordjournals.epirev.a000796

Source DB:  PubMed          Journal:  Epidemiol Rev        ISSN： 0193-936X            Impact factor:   6.222


× No keyword cloud information.
  18 in total

1.  Risk factors for prostate cancer.

Authors:  Peter H Gann
Journal:  Rev Urol       Date:  2002

2.  Enterolactone inhibits insulin-like growth factor-1 receptor signaling in human prostatic carcinoma PC-3 cells.

Authors:  Li-Hua Chen; Jing Fang; Zhijian Sun; Huaixing Li; Ying Wu; Wendy Demark-Wahnefried; Xu Lin
Journal:  J Nutr       Date:  2009-02-11       Impact factor: 4.798

Review 3.  Molecular alterations in prostate cancer as diagnostic, prognostic, and therapeutic targets.

Authors:  Bora Gurel; Tsuyoshi Iwata; Cheryl M Koh; Srinivasan Yegnasubramanian; William G Nelson; Angelo M De Marzo
Journal:  Adv Anat Pathol       Date:  2008-11       Impact factor: 3.875

4.  Dietary carbohydrate, glycemic index, glycemic load, and risk of prostate cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) cohort.

Authors:  James M Shikany; Andrew P Flood; Cari M Kitahara; Ann W Hsing; Tamra E Meyer; Bradley J Willcox; David T Redden; Regina G Ziegler
Journal:  Cancer Causes Control       Date:  2011-05-07       Impact factor: 2.506

5.  Carbohydrate intake, glycemic index and prostate cancer risk.

Authors:  Adriana C Vidal; Christina D Williams; Emma H Allott; Lauren E Howard; Delores J Grant; Megan McPhail; Katharine N Sourbeer; Lin Pao Hwa; Paolo Boffetta; Cathrine Hoyo; Stephen J Freedland
Journal:  Prostate       Date:  2014-11-21       Impact factor: 4.104

Review 6.  Circulating insulin-like growth factor peptides and prostate cancer risk: a systematic review and meta-analysis.

Authors:  Mari-Anne Rowlands; David Gunnell; Ross Harris; Lars J Vatten; Jeff M P Holly; Richard M Martin
Journal:  Int J Cancer       Date:  2009-05-15       Impact factor: 7.396

7.  Expression levels of insulin-like growth factors 1 and 2 in head and neck squamous cell carcinoma.

Authors:  Xu Zhi; Katarzyna Lamperska; Paweł Golusinski; Nicholas J Schork; Lukasz Luczewski; Wojciech Golusinski; Michal M Masternak
Journal:  Growth Horm IGF Res       Date:  2014-04-22       Impact factor: 2.372

8.  Inhibitory effects of nordihydroguaiaretic acid (NDGA) on the IGF-1 receptor and androgen dependent growth of LAPC-4 prostate cancer cells.

Authors:  Charles J Ryan; Marianna Zavodovskaya; Jack F Youngren; Michael Campbell; Marc Diamond; Jeremy Jones; Laura Shiry; Geoffrey Allan; Betty A Maddux; Ira D Goldfine
Journal:  Prostate       Date:  2008-08-01       Impact factor: 4.104

9.  Insulin-like growth factor-I, insulin-like growth factor binding protein-3 and risk of benign prostate hyperplasia in the prostate cancer prevention trial.

Authors:  Marian L Neuhouser; Jeannette Schenk; Yoon Ju Song; Catherine M Tangen; Phyllis J Goodman; Michael Pollak; David F Penson; Ian M Thompson; Alan R Kristal
Journal:  Prostate       Date:  2008-09-15       Impact factor: 4.104

10.  The insulin-like growth factor system and its receptors: A potential novel anticancer target.

Authors:  Colin R Lindsay; Tr Jeffry Evans
Journal:  Biologics       Date:  2008-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.